Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 265

1.

Peptide mimics of the Bowman-Birk inhibitor reactive site loop.

McBride JD, Watson EM, Brauer AB, Jaulent AM, Leatherbarrow RJ.

Biopolymers. 2002;66(2):79-92. Review.

PMID:
12325158
2.

Structural features and molecular evolution of Bowman-Birk protease inhibitors and their potential application.

Qi RF, Song ZW, Chi CW.

Acta Biochim Biophys Sin (Shanghai). 2005 May;37(5):283-92. Review.

PMID:
15880256
3.

Proteinase inhibition using small Bowman-Birk-type structures.

Fernandez JH, Mello MO, Galgaro L, Tanaka AS, Silva-Filho MC, Neshich G.

Genet Mol Res. 2007 Oct 5;6(4):846-58.

4.

Synthetic peptide mimics of the Bowman-Birk inhibitor protein.

McBride JD, Leatherbarrow RJ.

Curr Med Chem. 2001 Jul;8(8):909-17. Review.

PMID:
11375759
5.

Crystal structure of a 16 kDa double-headed Bowman-Birk trypsin inhibitor from barley seeds at 1.9 A resolution.

Song HK, Kim YS, Yang JK, Moon J, Lee JY, Suh SW.

J Mol Biol. 1999 Nov 12;293(5):1133-44.

PMID:
10547291
6.

The (1)H-NMR solution structure of the antitryptic core peptide of Bowman-Birk inhibitor proteins: a minimal canonical loop.

Brauer AB, Kelly G, Matthews SJ, Leatherbarrow RJ.

J Biomol Struct Dyn. 2002 Aug;20(1):59-70.

PMID:
12144352
7.

The Bowman-Birk inhibitor reactive site loop sequence represents an independent structural beta-hairpin motif.

Brauer AB, Kelly G, McBride JD, Cooke RM, Matthews SJ, Leatherbarrow RJ.

J Mol Biol. 2001 Mar 2;306(4):799-807. Erratum in: J Mol Biol 2001 May 4;308(3):565-6.

PMID:
11243789
8.

Solution structure of a novel C2-symmetrical bifunctional bicyclic inhibitor based on SFTI-1.

Jaulent AM, Brauer AB, Matthews SJ, Leatherbarrow RJ.

J Biomol NMR. 2005 Sep;33(1):57-62.

PMID:
16222558
9.

The absolute structural requirement for a proline in the P3'-position of Bowman-Birk protease inhibitors is surmounted in the minimized SFTI-1 scaffold.

Daly NL, Chen YK, Foley FM, Bansal PS, Bharathi R, Clark RJ, Sommerhoff CP, Craik DJ.

J Biol Chem. 2006 Aug 18;281(33):23668-75. Epub 2006 Jun 9.

10.

The Bowman-Birk inhibitor. Trypsin- and chymotrypsin-inhibitor from soybeans.

Birk Y.

Int J Pept Protein Res. 1985 Feb;25(2):113-31. Review.

PMID:
3886572
11.

A conserved cis peptide bond is necessary for the activity of Bowman-Birk inhibitor protein.

Brauer AB, Domingo GJ, Cooke RM, Matthews SJ, Leatherbarrow RJ.

Biochemistry. 2002 Aug 27;41(34):10608-15.

PMID:
12186545
12.
13.

Crystal structure of the Bowman-Birk inhibitor from barley seeds in ternary complex with porcine trypsin.

Park EY, Kim JA, Kim HW, Kim YS, Song HK.

J Mol Biol. 2004 Oct 8;343(1):173-86.

PMID:
15381428
14.
15.

Introduction of the new dipeptide isostere 7-endo-BtA as reverse turn inducer in a Bowman-Birk proteinase inhibitor: synthesis and conformational analysis.

Scarpi D, Occhiato EG, Trabocchi A, Leatherbarrow RJ, Brauer AB, Nievo M, Guarna A.

Bioorg Med Chem. 2001 Jun;9(6):1625-32.

PMID:
11408182
16.
17.

Synthesis of a mixture of cyclic peptides based on the Bowman-Birk reactive site loop to screen for serine protease inhibitors.

Domingo GJ, Leatherbarrow RJ, Freeman N, Patel S, Weir M.

Int J Pept Protein Res. 1995 Jul;46(1):79-87.

PMID:
7558601
18.

Bowman-Birk protease inhibitor from the seeds of Vigna unguiculata forms a highly stable dimeric structure.

Rao KN, Suresh CG.

Biochim Biophys Acta. 2007 Oct;1774(10):1264-73. Epub 2007 Aug 3.

PMID:
17869196
19.

Study of antiproteinase activity of acylated derivatives of Bowman-Birk soybean proteinase inhibitor.

Malykh EV, Larionova NI.

Biochemistry (Mosc). 2002 Dec;67(12):1383-7.

PMID:
12600268
20.

Design and inhibitory properties of synthetic Bowman-Birk loops.

Maeder DL, Sunde M, Botes DP.

Int J Pept Protein Res. 1992 Aug;40(2):97-102.

PMID:
1446974
Items per page

Supplemental Content

Write to the Help Desk